Jenna Glatzer is an Analyst at Catalio Capital Management, LP.
She is currently a PhD Candidate in the Cellular and Molecular Medicine Program at the Johns Hopkins School of Medicine. Her research uses techniques in CRISPR-Cas9 barcoding, immunology, cell biology, and optical microscopy to study the function of glial cells in the mouse central nervous system during healthy and disease states.
Jenna earned a B.S. in Biological Sciences: Neuroscience from the University of Rochester.